David Southwell – Biografia

David foi President and Chief Executive Officer para a Inotek Pharmaceuticals, e Director da Rocket Pharmaceuticals. David Southwell juntou-se à PTC Therapeutics em 2025.

David Southwell atualmente é

• Chief Executive Officer at Volastra Therapeutics - View - Volastra Therapeutics org chart

• Senior Director of Engineering and Head of Site Reliability Engineering at Pex - View - Pex org chart

• Board Member at Sensorium Therapeutics - View - Sensorium Therapeutics org chart

• Chairman of the Board at Revolo Biotherapeutics - View - Revolo Biotherapeutics org chart

• Director at Rocket Pharmaceuticals - View - Rocket Pharmaceuticals org chart

• Member of the Board at PTC Therapeutics - View - PTC Therapeutics org chart

Criar um alerta
para seguir a carreira de David Southwell.

David Southwell é um Bachelor of Arts in Economics pela Rice University e um Master of Business Administration pela Dartmouth College - The Tuck School of Business .

Eles também estudaram em Rice University:

• James Turley - Citigroup

• John Doerr - Alphabet Inc

• Dilip Venkatachari - US Bank

Encontre 0a Rice University

Eles também estudaram em Dartmouth College - The Tuck School of Business:

• Alastair Borthwick - Bank of America
• Michael Cleary - Wells Fargo
• Rob Mailloux - Honeywell

Encontre 0a Dartmouth College - The Tuck School of Business

Aqui estão algumas sugestões para fazer contato com sucesso.